Brian R Froelke

Brian R. Froelke, MD

Specializes In
  • Emergency Medicine
Languages Spoken
  • English


Sees Patients For

Emergency medicine, emergency medical services, disaster medicine, disaster preparedness, hazardous materials, tactical medicine, anti-terrorism, homeland security, drug overdose, sepsis, asthma

Hospital Affiliations

  • Barnes-Jewish Hospital
  • Christian Hospital



Board Certifications

  • Emergency Medicine
  • Emergency Medicine EMS

Academic Title(s)

Assistant Professor, Emergency Medicine

Other positions:
President, CMO Interstate Disaster Medical Collaborative
Chief Medical Officer, Missouri Disaster Response System
Missouri East Central EMS Regional Medical Director
Christian Hospital EMS Medical Director

Research Interests

Pediatric disaster preparedness study, geriatric pre-hospital fall risk assessment project, effects of delayed activated charcoal on acetaminophen overdose

Publications & Research

View research profile »



1998 University of Notre Dame, Notre Dame, IN


2007 Emergency Medicine, Barnes-Jewish Hospital St. Louis, MO


2002 University of Cincinnati Medical School


2006 Emergency Medicine, Barnes-Jewish Hospital St. Louis, MO

Chief Resident

2006 Emergency Medicine, Barnes-Jewish Hospital St. Louis, MO

Financial Disclosures
  • FluidIQ
    • Royalties: $1 - $9,999
    • Equity: Yes
    • Consulting/Advisory Board: $1 - $9,999
    • Reporting Date: 05/01/2023
  • MedAware
    • Equity: Yes
    • Reporting Date: 05/01/2023
  • Ploto
    • Equity: Yes
    • Reporting Date: 05/01/2023

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.